APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Obesity Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pediatric Obesity Management Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchPediatric Obesity Management Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Obesity Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pediatric Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Obesity Management Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Obesity Management Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pediatric Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pediatric Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pediatric Obesity Management market include Takeda Pharmaceutical Company, Pfizer, GlaxoSmithKline, VIVUS, Herbalife, F.Hoffmann-La Roche, Ethicon, Inc., Currax Pharmaceuticals and AstraZeneca,, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Obesity Management market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Obesity Management and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Obesity Management sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Obesity Management market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Obesity Management Segment by Company

Takeda Pharmaceutical Company

Pfizer

GlaxoSmithKline

VIVUS

Herbalife

F.Hoffmann-La Roche

Ethicon, Inc.

Currax Pharmaceuticals

AstraZeneca,

ApolloEndosurgery

Pediatric Obesity Management Segment by Type

Phentermine

Liraglutide

Lorcaserin

Setmelanotide

Others

Pediatric Obesity Management Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Pediatric Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pediatric Obesity Management status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pediatric Obesity Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pediatric Obesity Management significant trends, drivers, influence factors in global and regions.

6. To analyze Pediatric Obesity Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Obesity Management market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediatric Obesity Management industry.

Chapter 3: Detailed analysis of Pediatric Obesity Management manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pediatric Obesity Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pediatric Obesity Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pediatric Obesity Management Industry Trends Table 2. Pediatric Obesity Management Industry Drivers Table 3. Pediatric Obesity Management Industry Opportunities and Challenges Table 4. Pediatric Obesity Management Industry Restraints Table 5. Global Pediatric Obesity Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pediatric Obesity Management Revenue Share by Company (2021-2026) Table 7. Global Pediatric Obesity Management Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pediatric Obesity Management Sales Volume Share by Company (2021-2026) Table 9. Global Pediatric Obesity Management Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pediatric Obesity Management Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pediatric Obesity Management Key Company Manufacturing Base & Headquarters Table 12. Global Pediatric Obesity Management Company, Product Type & Application Table 13. Global Pediatric Obesity Management Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Obesity Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Phentermine Table 18. Significant Companies of Liraglutide Table 19. Significant Companies of Lorcaserin Table 20. Significant Companies of Setmelanotide Table 21. Significant Companies of Others Table 22. Global Pediatric Obesity Management Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Pediatric Obesity Management Sales Volume by Type (2021-2026) & (k units) Table 24. Global Pediatric Obesity Management Sales Volume by Type (2027-2032) & (k units) Table 25. Global Pediatric Obesity Management Sales Volume Share by Type (2021-2026) Table 26. Global Pediatric Obesity Management Sales Volume Share by Type (2027-2032) Table 27. Global Pediatric Obesity Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pediatric Obesity Management Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pediatric Obesity Management Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pediatric Obesity Management Sales Value Share by Type (2021-2026) Table 31. Global Pediatric Obesity Management Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Hospital Pharmacies Table 34. Significant Companies of Retail Pharmacies Table 35. Global Pediatric Obesity Management Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Pediatric Obesity Management Sales Volume by Application (2021-2026) & (k units) Table 37. Global Pediatric Obesity Management Sales Volume by Application (2027-2032) & (k units) Table 38. Global Pediatric Obesity Management Sales Volume Share by Application (2021-2026) Table 39. Global Pediatric Obesity Management Sales Volume Share by Application (2027-2032) Table 40. Global Pediatric Obesity Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Pediatric Obesity Management Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Pediatric Obesity Management Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Pediatric Obesity Management Sales Value Share by Application (2021-2026) Table 44. Global Pediatric Obesity Management Sales Value Share by Application (2027-2032) Table 45. Global Pediatric Obesity Management Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Pediatric Obesity Management Sales by Region (2021-2026) & (k units) Table 47. Global Pediatric Obesity Management Sales Market Share by Region (2021-2026) Table 48. Global Pediatric Obesity Management Sales by Region (2027-2032) & (k units) Table 49. Global Pediatric Obesity Management Sales Market Share by Region (2027-2032) Table 50. Global Pediatric Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pediatric Obesity Management Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Pediatric Obesity Management Sales Value Share by Region (2021-2026) Table 53. Global Pediatric Obesity Management Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Pediatric Obesity Management Sales Value Share by Region (2027-2032) Table 55. Global Pediatric Obesity Management Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Pediatric Obesity Management Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Pediatric Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 60. Global Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 61. Global Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 62. Global Pediatric Obesity Management Sales Market Share by Country (2027-2032) Table 63. Global Pediatric Obesity Management Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Pediatric Obesity Management Sales Value Market Share by Country (2021-2026) Table 65. Global Pediatric Obesity Management Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Pediatric Obesity Management Sales Value Market Share by Country (2027-2032) Table 67. Takeda Pharmaceutical Company Company Information Table 68. Takeda Pharmaceutical Company Business Overview Table 69. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio Table 71. Takeda Pharmaceutical Company Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Pfizer Pediatric Obesity Management Product Portfolio Table 76. Pfizer Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Pediatric Obesity Management Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. VIVUS Company Information Table 83. VIVUS Business Overview Table 84. VIVUS Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. VIVUS Pediatric Obesity Management Product Portfolio Table 86. VIVUS Recent Development Table 87. Herbalife Company Information Table 88. Herbalife Business Overview Table 89. Herbalife Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Herbalife Pediatric Obesity Management Product Portfolio Table 91. Herbalife Recent Development Table 92. F.Hoffmann-La Roche Company Information Table 93. F.Hoffmann-La Roche Business Overview Table 94. F.Hoffmann-La Roche Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio Table 96. F.Hoffmann-La Roche Recent Development Table 97. Ethicon, Inc. Company Information Table 98. Ethicon, Inc. Business Overview Table 99. Ethicon, Inc. Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Ethicon, Inc. Pediatric Obesity Management Product Portfolio Table 101. Ethicon, Inc. Recent Development Table 102. Currax Pharmaceuticals Company Information Table 103. Currax Pharmaceuticals Business Overview Table 104. Currax Pharmaceuticals Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio Table 106. Currax Pharmaceuticals Recent Development Table 107. AstraZeneca, Company Information Table 108. AstraZeneca, Business Overview Table 109. AstraZeneca, Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. AstraZeneca, Pediatric Obesity Management Product Portfolio Table 111. AstraZeneca, Recent Development Table 112. ApolloEndosurgery Company Information Table 113. ApolloEndosurgery Business Overview Table 114. ApolloEndosurgery Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. ApolloEndosurgery Pediatric Obesity Management Product Portfolio Table 116. ApolloEndosurgery Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Pediatric Obesity Management Distributors List Table 120. Pediatric Obesity Management Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Pediatric Obesity Management Product Image Figure 2. Global Pediatric Obesity Management Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pediatric Obesity Management Sales (2021-2032) & (k units) Figure 5. Global Pediatric Obesity Management Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pediatric Obesity Management Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Phentermine Image Figure 10. Liraglutide Image Figure 11. Lorcaserin Image Figure 12. Setmelanotide Image Figure 13. Others Image Figure 14. Global Pediatric Obesity Management Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Pediatric Obesity Management Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pediatric Obesity Management Sales Volume Share by Type (2021-2032) Figure 17. Global Pediatric Obesity Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pediatric Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pediatric Obesity Management Sales Value Share by Type (2021-2032) Figure 20. Online Pharmacies Image Figure 21. Hospital Pharmacies Image Figure 22. Retail Pharmacies Image Figure 23. Global Pediatric Obesity Management Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pediatric Obesity Management Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Pediatric Obesity Management Sales Volume Share by Application (2021-2032) Figure 26. Global Pediatric Obesity Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pediatric Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Pediatric Obesity Management Sales Value Share by Application (2021-2032) Figure 29. Global Pediatric Obesity Management Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Pediatric Obesity Management Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Pediatric Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Pediatric Obesity Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 34. North America Pediatric Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Pediatric Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pediatric Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 40. South America Pediatric Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Pediatric Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Pediatric Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Pediatric Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Pediatric Obesity Management Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Pediatric Obesity Management Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Phentermine
  • Liraglutide
  • Lorcaserin
  • Setmelanotide
  • Others
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical Company
  • Pfizer
  • GlaxoSmithKline
  • VIVUS
  • Herbalife
  • F.Hoffmann-La Roche
  • Ethicon, Inc.
  • Currax Pharmaceuticals
  • AstraZeneca,
  • ApolloEndosurgery

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Obesity Management Sales Value (2021-2032)
  4. 1.2.2 Global Pediatric Obesity Management Sales Volume (2021-2032)
  5. 1.2.3 Global Pediatric Obesity Management Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pediatric Obesity Management Market Dynamics
  1. 2.1 Pediatric Obesity Management Industry Trends
  2. 2.2 Pediatric Obesity Management Industry Drivers
  3. 2.3 Pediatric Obesity Management Industry Opportunities and Challenges
  4. 2.4 Pediatric Obesity Management Industry Restraints
3 Pediatric Obesity Management Market by Company
  1. 3.1 Global Pediatric Obesity Management Company Revenue Ranking in 2025
  2. 3.2 Global Pediatric Obesity Management Revenue by Company (2021-2026)
  3. 3.3 Global Pediatric Obesity Management Sales Volume by Company (2021-2026)
  4. 3.4 Global Pediatric Obesity Management Average Price by Company (2021-2026)
  5. 3.5 Global Pediatric Obesity Management Company Ranking (2024-2026)
  6. 3.6 Global Pediatric Obesity Management Company Manufacturing Base and Headquarters
  7. 3.7 Global Pediatric Obesity Management Company Product Type and Application
  8. 3.8 Global Pediatric Obesity Management Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pediatric Obesity Management Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pediatric Obesity Management Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pediatric Obesity Management Market by Type
  1. 4.1 Pediatric Obesity Management Type Introduction
  2. 4.1.1 Phentermine
  3. 4.1.2 Liraglutide
  4. 4.1.3 Lorcaserin
  5. 4.1.4 Setmelanotide
  6. 4.1.5 Others
  7. 4.2 Global Pediatric Obesity Management Sales Volume by Type
  8. 4.2.1 Global Pediatric Obesity Management Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pediatric Obesity Management Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pediatric Obesity Management Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pediatric Obesity Management Sales Value by Type
  12. 4.3.1 Global Pediatric Obesity Management Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pediatric Obesity Management Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pediatric Obesity Management Sales Value Share by Type (2021-2032)
5 Pediatric Obesity Management Market by Application
  1. 5.1 Pediatric Obesity Management Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Pediatric Obesity Management Sales Volume by Application
  6. 5.2.1 Global Pediatric Obesity Management Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Obesity Management Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pediatric Obesity Management Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pediatric Obesity Management Sales Value by Application
  10. 5.3.1 Global Pediatric Obesity Management Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pediatric Obesity Management Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pediatric Obesity Management Sales Value Share by Application (2021-2032)
6 Pediatric Obesity Management Regional Sales and Value Analysis
  1. 6.1 Global Pediatric Obesity Management Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Obesity Management Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Obesity Management Sales by Region: 2021-2026
  4. 6.2.2 Global Pediatric Obesity Management Sales by Region (2027-2032)
  5. 6.3 Global Pediatric Obesity Management Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pediatric Obesity Management Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pediatric Obesity Management Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pediatric Obesity Management Sales Value by Region (2027-2032)
  9. 6.5 Global Pediatric Obesity Management Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pediatric Obesity Management Sales Value (2021-2032)
  12. 6.6.2 North America Pediatric Obesity Management Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pediatric Obesity Management Sales Value (2021-2032)
  15. 6.7.2 Europe Pediatric Obesity Management Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pediatric Obesity Management Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pediatric Obesity Management Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pediatric Obesity Management Sales Value (2021-2032)
  21. 6.9.2 South America Pediatric Obesity Management Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pediatric Obesity Management Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pediatric Obesity Management Sales Value Share by Country, 2025 VS 2032
7 Pediatric Obesity Management Country-level Sales and Value Analysis
  1. 7.1 Global Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pediatric Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pediatric Obesity Management Sales by Country (2021-2032)
  4. 7.3.1 Global Pediatric Obesity Management Sales by Country (2021-2026)
  5. 7.3.2 Global Pediatric Obesity Management Sales by Country (2027-2032)
  6. 7.4 Global Pediatric Obesity Management Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pediatric Obesity Management Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pediatric Obesity Management Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pediatric Obesity Management Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pediatric Obesity Management Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pediatric Obesity Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company
  2. 8.1.1 Takeda Pharmaceutical Company Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Pediatric Obesity Management Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Pediatric Obesity Management Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 VIVUS
  20. 8.4.1 VIVUS Company Information
  21. 8.4.2 VIVUS Business Overview
  22. 8.4.3 VIVUS Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 VIVUS Pediatric Obesity Management Product Portfolio
  24. 8.4.5 VIVUS Recent Developments
  25. 8.5 Herbalife
  26. 8.5.1 Herbalife Company Information
  27. 8.5.2 Herbalife Business Overview
  28. 8.5.3 Herbalife Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Herbalife Pediatric Obesity Management Product Portfolio
  30. 8.5.5 Herbalife Recent Developments
  31. 8.6 F.Hoffmann-La Roche
  32. 8.6.1 F.Hoffmann-La Roche Company Information
  33. 8.6.2 F.Hoffmann-La Roche Business Overview
  34. 8.6.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio
  36. 8.6.5 F.Hoffmann-La Roche Recent Developments
  37. 8.7 Ethicon, Inc.
  38. 8.7.1 Ethicon, Inc. Company Information
  39. 8.7.2 Ethicon, Inc. Business Overview
  40. 8.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ethicon, Inc. Pediatric Obesity Management Product Portfolio
  42. 8.7.5 Ethicon, Inc. Recent Developments
  43. 8.8 Currax Pharmaceuticals
  44. 8.8.1 Currax Pharmaceuticals Company Information
  45. 8.8.2 Currax Pharmaceuticals Business Overview
  46. 8.8.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio
  48. 8.8.5 Currax Pharmaceuticals Recent Developments
  49. 8.9 AstraZeneca,
  50. 8.9.1 AstraZeneca, Company Information
  51. 8.9.2 AstraZeneca, Business Overview
  52. 8.9.3 AstraZeneca, Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca, Pediatric Obesity Management Product Portfolio
  54. 8.9.5 AstraZeneca, Recent Developments
  55. 8.10 ApolloEndosurgery
  56. 8.10.1 ApolloEndosurgery Company Information
  57. 8.10.2 ApolloEndosurgery Business Overview
  58. 8.10.3 ApolloEndosurgery Pediatric Obesity Management Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ApolloEndosurgery Pediatric Obesity Management Product Portfolio
  60. 8.10.5 ApolloEndosurgery Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Obesity Management Value Chain Analysis
  2. 9.1.1 Pediatric Obesity Management Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Obesity Management Sales Mode & Process
  6. 9.2 Pediatric Obesity Management Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Obesity Management Distributors
  9. 9.2.3 Pediatric Obesity Management Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst